| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |